Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
CME in Minutes: Education in Oncology & Hematology - Alexander I. Spira, MD, PhD, FACP - Biomarkers at the Forefront: The Crucial Role of Testing Across Solid Tumor Types

Alexander I. Spira, MD, PhD, FACP - Biomarkers at the Forefront: The Crucial Role of Testing Across Solid Tumor Types

CME in Minutes: Education in Oncology & Hematology

12/13/24 • 15 min

plus icon
bookmark
Share icon
Please visit answersincme.com/SWT860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses the importance of biomarker testing in solid tumors. Upon completion of this activity, participants should be better able to: Recognize the impact of biomarker testing on patient outcomes across tumor types; Identify optimal strategies for implementing biomarker testing in clinical practice; and Outline patient-centered strategies to optimize outcomes following identification of actionable biomarkers/mutations.

12/13/24 • 15 min

plus icon
bookmark
Share icon

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/cme-in-minutes-education-in-oncology-and-hematology-449630/alexander-i-spira-md-phd-facp-biomarkers-at-the-forefront-the-crucial-80058972"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to alexander i. spira, md, phd, facp - biomarkers at the forefront: the crucial role of testing across solid tumor types on goodpods" style="width: 225px" /> </a>

Copy